Investors Sell Shares of Amsurg Corp. (AMSG) on Strength (AMSG)
Investors sold shares of Amsurg Corp. (NASDAQ:AMSG) on strength during trading hours on Monday. $14.91 million flowed into the stock on the tick-up and $68.63 million flowed out of the stock on the tick-down, for a money net flow of $53.72 million out of the stock. Of all stocks tracked, Amsurg Corp. had the 7th highest net out-flow for the day. Amsurg Corp. traded up $1.89 for the day and closed at $67.29
A number of research firms have issued reports on AMSG. Mizuho lifted their target price on shares of Amsurg Corp. from $90.00 to $95.00 and gave the company a “buy” rating in a research note on Friday, June 24th. Barclays PLC began coverage on shares of Amsurg Corp. in a research note on Wednesday, June 1st. They issued an “equal weight” rating and a $85.00 target price for the company. Bank of America Corp. upgraded shares of Amsurg Corp. from a “neutral” rating to a “buy” rating and set a $104.00 target price for the company in a research note on Thursday, June 16th. Wells Fargo & Co. began coverage on shares of Amsurg Corp. in a research note on Tuesday, June 14th. They issued a “market perform” rating for the company. Finally, Robert W. Baird reiterated a “buy” rating on shares of Amsurg Corp. in a research note on Monday, May 16th. Four research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $93.91.
The company has a market cap of $3.62 billion and a price-to-earnings ratio of 19.97. The stock has a 50-day moving average price of $69.92 and a 200 day moving average price of $74.07.
Amsurg Corp. (NASDAQ:AMSG) last issued its quarterly earnings results on Tuesday, August 2nd. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.02. The business had revenue of $758.50 million for the quarter, compared to the consensus estimate of $769.88 million. During the same period in the prior year, the business earned $0.97 earnings per share. Amsurg Corp.’s revenue was up 21.5% compared to the same quarter last year. On average, equities research analysts expect that Amsurg Corp. will post $4.33 EPS for the current fiscal year.
In other news, insider Robert Jon Coward sold 7,500 shares of the firm’s stock in a transaction that occurred on Thursday, August 18th. The shares were sold at an average price of $64.36, for a total transaction of $482,700.00. Following the completion of the transaction, the insider now directly owns 105,007 shares of the company’s stock, valued at approximately $6,758,250.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
A hedge fund recently raised its stake in Amsurg Corp. stock. Dimensional Fund Advisors LP raised its stake in Amsurg Corp. (NASDAQ:AMSG) by 3.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,994,029 shares of the company’s stock after buying an additional 92,088 shares during the period. Dimensional Fund Advisors LP owned 6.27% of Amsurg Corp. worth $227,552,000 at the end of the most recent quarter.
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.